GRI Bio, Inc. (GRI)
1.93
+0.09
(+4.89%)
USD |
NASDAQ |
Sep 18, 16:00
1.90
-0.03
(-1.55%)
After-Hours: 20:00
GRI Bio Price : 1.93 for Sept. 18, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 18, 2026 | 1.86 | 1.96 | 1.77 | 1.93 | 114255.0 |
| Sep 17, 2026 | 1.77 | 1.91 | 1.72 | 1.84 | 174238.0 |
| Sep 16, 2026 | 1.81 | 1.85 | 1.75 | 1.81 | 48011.00 |
| Sep 15, 2026 | 1.89 | 1.89 | 1.80 | 1.82 | 69477.00 |
| Sep 14, 2026 | 1.86 | 1.97 | 1.86 | 1.89 | 105314.0 |
| Sep 11, 2026 | 1.99 | 2.05 | 1.85 | 1.90 | 131906.0 |
| Sep 10, 2026 | 1.79 | 2.00 | 1.78 | 1.94 | 214312.0 |
| Sep 09, 2026 | 1.97 | 1.97 | 1.76 | 1.80 | 201651.0 |
| Sep 08, 2026 | 2.61 | 2.67 | 1.90 | 2.00 | 733748.0 |
| Sep 04, 2026 | 2.34 | 3.36 | 2.33 | 2.88 | 7.465M |
| Sep 03, 2026 | 2.08 | 2.50 | 2.01 | 2.29 | 1.605M |
| Sep 02, 2026 | 1.92 | 2.02 | 1.87 | 2.00 | 85829.00 |
| Sep 01, 2026 | 1.90 | 1.98 | 1.84 | 1.91 | 42453.00 |
| Aug 31, 2026 | 1.93 | 1.97 | 1.86 | 1.92 | 51893.00 |
| Aug 28, 2026 | 2.05 | 2.07 | 1.91 | 1.92 | 34866.00 |
| Aug 27, 2026 | 1.821 | 2.10 | 1.821 | 2.07 | 78644.00 |
| Aug 26, 2026 | 1.96 | 1.96 | 1.830 | 1.91 | 44257.00 |
| Aug 25, 2026 | 1.80 | 1.98 | 1.785 | 1.96 | 127508.0 |
| Aug 24, 2026 | 1.80 | 1.94 | 1.759 | 1.79 | 267395.0 |
| Aug 21, 2026 | 1.71 | 1.73 | 1.65 | 1.65 | 83147.00 |
| Aug 20, 2026 | 1.73 | 1.77 | 1.664 | 1.67 | 27588.00 |
| Aug 19, 2026 | 1.75 | 1.792 | 1.69 | 1.73 | 61642.00 |
| Aug 18, 2026 | 1.74 | 1.80 | 1.691 | 1.71 | 45730.00 |
| Aug 17, 2026 | 1.67 | 1.75 | 1.61 | 1.73 | 57052.00 |
| Aug 14, 2026 | 1.82 | 1.82 | 1.66 | 1.67 | 106512.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| ACADIA Pharmaceuticals, Inc. | 27.29 |
| Alnylam Pharmaceuticals, Inc. | 239.56 |
| Anika Therapeutics, Inc. | 20.81 |
| Savara, Inc. | 5.37 |
| Vericel Corp. | 40.02 |
Price Related Metrics
| Price to Book Value | 0.4104 |
| Earnings Yield | -2.27K% |
| Market Cap | 4.219M |